BioMed Research International / 2009 / Article / Tab 2

Research Article

Comparability of Microarray Data between Amplified and Non Amplified RNA in Colorectal Carcinoma

Table 2

Different gene expression values of cancer specific genes between non amplified (NA) and amplified (PA) RNA samples from colorectal carcinoma samples.

Affy Gb BasesAnotationAvg. Signals NAAvg. Signals PAFC PA/NA

221455_s_atNM_03075356038Wingless-type MMTV integration site family, member 3 (WNT3).20784.04
212447_atAF16140223,589HSPC284 mRNA, partial cds.248096114.01
201111_atNM_00125350,649Brain cellular apoptosis susceptibility protein (CSE1).256874313.01
209056_s_atNM_00125362,329CDC5 (cell division cycle 5, S. pombe, homolog)-like (CDC5L).139938613.01
206458_s_atNM_02449454,746Wingless-type MMTV integration site family, member 2B (WNT2B).721772.01
207149_atL334771,102,757 Br-cadherin mRNA, complete cds.35842.04
204731_atNM_003243225,660Transforming growth factor, beta receptor III (TGFBR3).60213362.04
219226_atNM_01650773,062CDC2-related protein kinase 7 (CrkRS).55511312.01
217366_atZ379943620Alpha E-catenin pseudogene.3062.04
208504_x_atNM_0189313321Protocadherin beta 11 (PCDHB11).33112.04
201069_atNM_00453027,516 Matrix metalloproteinase 2 (MMP2).1528887 .04
203968_s_atNM_00125415,268Cell division cycle 6 (CDC6).624338 .01
203918_atNM_00258725,296Protocadherin 1 (PCDH1).544290 .04
208756_atU367649235TGF-beta receptor interacting protein 1.44512355 .01
210838_s_atL1707515,944TGF-b superfamily receptor type I.277127 .01
206943_atNM_00461249,063Transforming growth factor, beta receptor I (TGFBR1).331150 .01
212143_s_atBF3402289028Insulin-like growth factor binding protein 3.1192462 .01
202039_atNM_0047402089TGFB1-induced antiapoptotic factor 1 (TIAF1).1000371 .01
203214_x_atNM_00178618927Cell division cycle 2, G1 to S and G2 to M (CDC2).31811174 .01
160020_atZ4848111,011Membrane-type matrix metalloproteinase 1 (MMP1).1258437 .01
217010_s_atAF27772446,558Cell division cycle 25C splice variant 3 (CDC25C).21161 .01
204696_s_atNM_00178931,134Cell division cycle 25A (CDC25A).12334 .01
203527_s_atNM_000038108,353Adenomatosis polyposis coli (APC).8523 .01
210287_s_atU01134192,877Soluble vascular endothelial cell growth factor receptor (sflt).14337 .01
203878_s_atNM_00594011,468Matrix metalloproteinase 11 (stromelysin 3) (MMP11).1546400 .01
203365_s_atNM_00242821,524Matrix metalloproteinase 15 (membrane-inserted) (MMP15).38893 .04
203683_s_atNM_0033773994Vascular endothelial growth factor B (VEGFB).42278 .01
217279_x_atX8353511,011Membrane-type matrix Metalloproteinase (MMP14).24427 .01
204380_s_atM5805115,565Fibroblast growth factor receptor (FGFR3).22425 .01
207334_s_atNM_00324287,641Transforming growth factor, beta receptor II (TGFBR2).32315 .01

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.